RxDoctor Payments Data

Vatinee Bunya, MD

Cornea and External Diseases Specialist · Philadelphia, PANPI 1760561799

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$294,141in research payments, 2019–2025

Across 23 payments — averaging $12,789 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$249K
  • Regeneron$44K
  • KOWA Company, LTD.$2K

How this compares

Too few cornea and external diseases specialist providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$43,092
Medicare patients
312
Services billed
549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine71$94,806
Cyclosporine63$47,521
XiidraLifitegrast38$42,858
TyrvayaVarenicline Tartrate12$8,172
ErythromycinErythromycin Base228$3,982
Latanoprost48$441
Timolol Maleate23$426

Paid to pharmacies, not to this prescriber.

Other cornea and external diseases specialist in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →